Candice Horbacz
The landscape of nicotine consumption is undergoing a profound transformation, presenting state legislatures across the United States with complex policy decisions regarding taxation. In 2026, consumers have an unprecedented array of options beyond traditional combustible cigarettes, with new products promising nicotine delivery at a significantly reduced harm profile. The advent and growing popularity of oral pouches, vaping devices (e-cigarettes), and heated tobacco products (HTPs) have necessitated a reevaluation of existing tax structures, which were largely designed for a bygone era of tobacco use. The Food and Drug Administration (FDA) has authorized a growing number of these alternative tobacco products (ATPs) for sale in the U.S., signaling their legitimacy in the market and compelling states to decide whether and how to levy taxes on them. This shift marks a critical juncture where public health objectives, revenue generation, and harm reduction strategies intersect, challenging traditional definitions and fiscal approaches.
The Shifting Landscape of Nicotine Consumption
For decades, the nicotine industry was synonymous with combustible cigarettes, a product category long understood to be highly detrimental to public health. Governments responded with significant excise taxes, aiming to both deter consumption and generate revenue to offset associated healthcare costs. However, the early 21st century witnessed the rise of innovative products designed to deliver nicotine without the combustion of tobacco, thereby reducing exposure to thousands of harmful chemicals. These products, initially met with skepticism and regulatory uncertainty, have steadily gained market share, driven by technological advancements and consumer demand for perceived safer alternatives.
The FDA plays a pivotal role in this evolving market. Through its Premarket Tobacco Product Application (PMTA) pathway, manufacturers must demonstrate that new tobacco products are "appropriate for the protection of public health" before they can be legally marketed. This rigorous process evaluates a product’s potential benefits to adult smokers who switch from combustible cigarettes, balanced against the risks of youth initiation and other population-level harms. While the number of FDA-authorized ATPs in the U.S. remains a fraction of those available globally or awaiting review, each authorization carries significant weight, confirming a product’s legal standing and prompting states to consider its place within their tax codes. The FDA’s authorization of specific HTPs and e-cigarettes, for instance, has lent credibility to their harm reduction potential, even as public health advocates continue to raise concerns about youth access and addiction.
Traditional Tobacco Taxation: A Flawed Framework for Modern Products
The existing framework for tobacco taxation in the United States is deeply entrenched and relatively straightforward for traditional products. Every state currently imposes an excise tax on cigarettes, typically defined as a fixed amount per cigarette, easily applied through tax-paid stamps on standard 20-cigarette packs. This system, built on uniformity of product and packaging, has proven effective for revenue collection and compliance.
Beyond cigarettes, all states also tax "other tobacco products" (OTPs), a broad category encompassing items like loose tobacco, snuff, and chewing tobacco. However, the inherent diversity within the OTP category has led states to adopt varied taxation methods. Common approaches include ad quantum taxes based on weight (e.g., per ounce) or ad valorem taxes, which levy a percentage of the wholesale price. While these methods offer flexibility, they introduce complexities when applied to the next generation of nicotine products.
The primary challenge with ATPs, such as e-cigarettes and modern oral pouches, is their fundamental nature: many do not contain tobacco. E-liquids, for example, primarily consist of nicotine, propylene glycol, vegetable glycerin, and flavorings. Oral pouches often contain synthetic nicotine or tobacco-derived nicotine salts without tobacco leaf. This distinction means they typically fall outside the traditional legal definition of "other tobacco products," creating a statutory gap in many states’ tax laws. Heated tobacco products, while containing tobacco, present a different dilemma. As products designed to reduce harm compared to traditional cigarettes, taxing them at the same rate as more harmful OTPs might contradict the public health goal of encouraging adult smokers to switch to less harmful alternatives. Consequently, states are faced with the imperative to either redefine their OTP categories to encompass these novel products or, more commonly, establish entirely new tax classifications specifically for ATPs.
States Grapple with New Tax Categories: A Patchwork of Policies
The regulatory response at the state level has been characterized by a rapid, yet inconsistent, evolution. As of January 2025, 33 states and the District of Columbia had already enacted excise taxes on vaping products and e-cigarettes. However, the lack of uniformity in these policies highlights the struggle to find an optimal approach. Some states have opted for ad valorem taxes, taxing a percentage of the manufacturer, wholesale, or retail price. Others employ ad quantum taxes based on product volume (e.g., per milliliter of e-liquid) or the number of cartridges. A further layer of complexity is introduced by states implementing bifurcated systems, with different structures and rates for "open systems" (refillable devices) versus "closed systems" (pre-filled pods). This fragmented approach creates administrative burdens for manufacturers and distributors operating across state lines and can lead to uneven consumer prices and cross-border purchasing behaviors.
The taxation of modern oral pouches is an even more nascent area. As of early 2026, only 18 states had levied specific taxes on these products, reflecting their more recent market penetration and the slower legislative adaptation. However, with the continued growth of the ATP market and increasing awareness of their presence, numerous states are actively considering new or increased taxes on these products in the upcoming legislative sessions. The following outlines a few prominent policy proposals emerging as of early 2026, though it is crucial to note that legislative processes are dynamic, and proposals are subject to change.
Legislative Spotlight: Diverse Approaches to ATP Taxation in 2026
The legislative sessions of 2026 are poised to be critical for the future of ATP taxation, with several states proposing significant reforms. These proposals showcase the diverse strategies states are employing to address the challenges of the modern nicotine market, often balancing revenue needs with public health goals.
Delaware: Governor Matt Meyer (D) unveiled his proposed 2027 budget, which includes a notable increase in the tax on OTPs. Crucially, the budget also specifically proposes raising taxes on vapor products to 10 cents per milliliter. This ad quantum approach for vapes provides a clear, volumetric tax, while the OTP increase would affect traditional non-cigarette tobacco products. The impact would likely be a direct increase in consumer prices for both categories, potentially driving down consumption and increasing state revenue. This move signals Delaware’s intent to align its tax policy with the evolving market and generate additional funds, possibly earmarked for public health initiatives or general revenue.
Nebraska: Legislative Bill (LB) 1238 in Nebraska aims to standardize the excise tax rate across a broad spectrum of nicotine products. The bill proposes setting the tax rate for all tobacco, electronic nicotine delivery systems, nicotine analogues, and ATPs at 30 percent of the wholesale cost. This comprehensive ad valorem approach seeks to equalize the tax burden across all nicotine-containing products, regardless of their form or specific composition. If passed, LB 1238 would represent a substantial tax increase for many ATPs, which may currently be untaxed or taxed at lower rates, potentially impacting their affordability and competitiveness against traditional cigarettes. While promoting tax parity, such a blanket increase could also be criticized for not differentiating based on harm reduction potential.
New York: Governor Hochul’s (D) 2027 Executive Budget includes multiple excise tax increases targeting ATPs, reflecting New York’s historically robust approach to tobacco control. The budget proposes expanding the definition of OTPs to explicitly include modern oral pouches, thereby subjecting them to the state’s existing 75 percent wholesale OTP tax rate. This would make oral pouches significantly more expensive. Furthermore, New York plans to add a specific $0.55 per unit tax on vapor products, which would be layered on top of the current 20 percent retail tax. This bifurcated system, combining an ad valorem retail tax with an ad quantum per-unit tax, introduces considerable complexity for both retailers and consumers. The rationale behind such a move is likely to significantly increase revenue from these products while potentially deterring their use, especially among younger populations.
Vermont: Senate Bill (S-0198) in Vermont introduces a groundbreaking, yet controversial, approach to ATP taxation. It expands the definition of "OTP" or "tobacco substitute" to encompass nicotine pouches and electronic vaping devices. Uniquely, S-0198 would establish the country’s first tax structure differentiated by nicotine content. Under this proposal, tobacco substitutes with less than 5 mg/g nicotine would be taxed at 92 percent of the wholesale price (the current OTP rate). However, products with 5 mg/g or more nicotine would face an even higher tax rate of 100 percent of the wholesale price. Given the typical nicotine concentrations in many vaping products, most would likely fall into the higher tax category. While novel, this nicotine-based tax has been met with skepticism from some economic and public health experts who argue there is no significant economic or health justification for such a differential, potentially penalizing adult smokers attempting to switch to higher-nicotine vaping products to satisfy their addiction, which could inadvertently drive them back to cigarettes.
Washington: House Bill (HB) 2382 in Washington State proposes a substantial overhaul of its vaping tax. It would replace the state’s current per milliliter vaping tax with a high 95 percent wholesale tax. This represents a significant tax increase, likely intended to drastically raise revenue and discourage vaping. Furthermore, the bill proposes to cut in half the existing tax discount (effectively increasing the tax) given to products that have qualified as a Modified Risk Tobacco Product (MRTP) by the FDA. This specific provision signals a potential shift away from incentivizing less harmful products through tax breaks, raising concerns among harm reduction advocates who argue against equating MRTPs with other, more harmful products.
Utah: House Bill (HB) 0337 in Utah seeks to streamline its tax categories while increasing revenue. It would repeal the state’s existing tax categories for smokeless tobacco and nicotine pouches, moving these products instead into the broader OTP category. As Utah taxes OTPs at 86 percent of the wholesale price, this reclassification would result in a significant tax increase for these products. Additionally, HB 0337 would repeal the 50 percent tax reduction currently given to MRTPs, thereby increasing the tax burden on these products. Similar to Washington’s proposal, Utah’s approach indicates a move towards higher taxation across various ATPs, potentially without full consideration of their differentiated harm profiles.
The Principle of Harm Reduction in Tax Policy
The core debate surrounding ATP taxation often centers on the principle of harm reduction. Excise taxes are traditionally applied to "sin goods" like tobacco and alcohol, aiming to internalize the external costs these products impose on society (e.g., healthcare expenditures, lost productivity) and to disincentivize consumption. However, the emergence of ATPs, which are generally considered less harmful than combustible cigarettes, complicates this traditional model.
Public health organizations and tobacco control advocates often argue for high taxes on all nicotine products to deter initiation, particularly among youth, and to reduce overall nicotine addiction. Conversely, proponents of harm reduction argue that tax policy should differentiate between products based on their relative risk. A framework that assigns preferential tax rates to less harmful products could incentivize adult smokers to switch away from the deadliest form of nicotine delivery – combustible cigarettes – towards safer alternatives. This approach acknowledges that while nicotine itself is addictive, the vast majority of tobacco-related disease and death comes from the combustion of tobacco, not the nicotine itself.
The Tax Foundation, a prominent non-profit tax policy research organization, has extensively analyzed existing research on ATPs and proposed a tax framework designed to optimize harm reduction. Their framework assigns product categories based on several key factors: the degree of harm the product causes, how easily it acts as a substitute for combustible cigarettes, how easily it can be mass-consumed, and its addictive potential. The guiding principle is clear: the safer a product, the more readily it substitutes for cigarettes, the slower its consumption rate, and the less addictive it is, the lower its tax rate should be.
Under this framework, less harmful products would receive a tax rate that is 50-100 percent lower than the tax rate applied to combustible cigarettes. For example, if cigarettes are taxed at $2.00 per pack, a less harmful vape or oral pouch might be taxed at $0.50 to $1.00 per unit/volume. Creating these tax rates as a percentage of cigarette tax rates helps ensure meaningful price differentials that actively incentivize consumers to switch from higher-risk products to lower-risk ones. This approach also offers a relatively straightforward mechanism for legislators to adopt at any level of government, providing consistency and predictability.
While an actual table cannot be rendered here, the Tax Foundation’s "Table 1. Alternative Tobacco Product Tax Rates to Optimize Harm Reduction" conceptually illustrates this differentiation. It typically categorizes products like smokeless tobacco, e-cigarettes, and oral pouches, and heated tobacco products, assigning them progressively lower tax rates compared to combustible cigarettes, reflecting their relative positions on the harm continuum. For instance, an ideal framework might place combustible cigarettes at the highest tax rate, followed by traditional smokeless tobacco. Heated tobacco products and open-system vapor products might occupy a middle tier, while nicotine pouches and closed-system vapor products, perceived as potentially lower risk and less amenable to illicit modification, could receive the lowest excise tax rates among nicotine products.
Challenges and Future Outlook
Creating effective public policy around new and rapidly evolving products like ATPs is inherently challenging. The continuous innovation in the nicotine market means that tax definitions and rates must be agile enough to adapt without stifling innovation or creating unintended consequences. The "youth vaping epidemic," a significant public health concern, adds another layer of complexity, often leading policymakers to impose higher taxes on all ATPs to deter underage use, potentially at the expense of harm reduction opportunities for adult smokers.
States face the difficult task of balancing the need for revenue generation, especially in tight fiscal environments, with public health goals. While higher taxes can generate significant revenue, overly aggressive taxation on less harmful products might inadvertently push adult smokers back to combustible cigarettes or encourage the growth of illicit markets. Moreover, the inconsistent tax policies across states can lead to "tax shopping," where consumers purchase products in neighboring jurisdictions with lower rates, undermining state revenue goals.
As more ATPs receive marketing approval from the FDA, confirming their legal status and, in some cases, their modified risk potential, more products will enter U.S. shelves. Establishing appropriate, coherent, and evidence-based tax policy is essential not only to create compliant, legal markets but also to strategically guide consumer behavior. The long-term objective should be to foster an environment where adult smokers are encouraged, through price signals and product availability, to move toward less harmful products, while simultaneously implementing robust measures to prevent nicotine initiation among youth. The legislative debates of 2026 and beyond will be crucial in shaping this future, demanding careful consideration of both economic impacts and public health imperatives.
